Guidant gains FDA nod for ENDOTAK ICD (implantable cardioverter defibrillator) lead:
This article was originally published in Clinica
Executive Summary
Guidant has gained FDA go-ahead to market in the US its ENDOTAK reliance active-fixation defibrillation lead, which it says features a simplified fixation system that allows smooth deployment into the heart wall. The lead, which transmits signals between the heart and the ICD device, has fluoroscopic markers to enable surgeons to clearly see the helix-shaped tip extending into the tissue. The product will be released in the US later this month, said the firm.